Intuitive Surgical (NASDAQ:ISRG) Rating Increased to Buy at Erste Group Bank

Erste Group Bank upgraded shares of Intuitive Surgical (NASDAQ:ISRG - Free Report) from a hold rating to a buy rating in a report published on Tuesday morning,Benzinga reports.

Several other equities analysts have also issued reports on ISRG. Piper Sandler reissued an "overweight" rating and set a $538.00 target price (up previously from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. Mizuho increased their price target on shares of Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. BTIG Research set a $535.00 price objective on shares of Intuitive Surgical in a report on Friday, October 18th. The Goldman Sachs Group set a $604.00 target price on shares of Intuitive Surgical in a research note on Friday, October 18th. Finally, Redburn Atlantic raised shares of Intuitive Surgical from a "neutral" rating to a "buy" rating and raised their price target for the company from $380.00 to $510.00 in a research report on Friday, August 2nd. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have assigned a buy rating to the company's stock. According to data from MarketBeat, Intuitive Surgical has a consensus rating of "Moderate Buy" and a consensus price target of $524.61.

Intuitive Surgical Stock Performance

Shares of ISRG stock traded up $7.18 on Tuesday, hitting $538.82. 1,118,896 shares of the stock traded hands, compared to its average volume of 1,458,894. Intuitive Surgical has a twelve month low of $304.50 and a twelve month high of $544.38. The firm's 50-day moving average price is $501.42 and its two-hundred day moving average price is $460.69. The stock has a market capitalization of $191.92 billion, a PE ratio of 86.63, a PEG ratio of 5.19 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating the consensus estimate of $1.24 by $0.32. The firm had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. On average, equities research analysts anticipate that Intuitive Surgical will post 5.45 EPS for the current fiscal year.

Insider Buying and Selling

In other news, Director Amy L. Ladd sold 450 shares of the stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $490.28, for a total value of $220,626.00. Following the completion of the sale, the director now directly owns 821 shares of the company's stock, valued at approximately $402,519.88. This represents a 35.41 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, General Counsel Gary Loeb sold 300 shares of the company's stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $475.00, for a total transaction of $142,500.00. Following the completion of the sale, the general counsel now directly owns 1,595 shares of the company's stock, valued at $757,625. The trade was a 15.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 91,178 shares of company stock worth $45,897,071 in the last ninety days. 0.80% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Intuitive Surgical

Hedge funds and other institutional investors have recently bought and sold shares of the company. M&T Bank Corp increased its holdings in Intuitive Surgical by 0.3% during the 3rd quarter. M&T Bank Corp now owns 68,581 shares of the medical equipment provider's stock valued at $33,691,000 after acquiring an additional 226 shares in the last quarter. Soltis Investment Advisors LLC increased its stake in shares of Intuitive Surgical by 12.6% during the 3rd quarter. Soltis Investment Advisors LLC now owns 519 shares of the medical equipment provider's stock worth $255,000 after purchasing an additional 58 shares in the last quarter. Virtue Capital Management LLC raised its position in shares of Intuitive Surgical by 7.7% during the 3rd quarter. Virtue Capital Management LLC now owns 1,635 shares of the medical equipment provider's stock worth $803,000 after purchasing an additional 117 shares during the last quarter. Arete Wealth Advisors LLC purchased a new stake in Intuitive Surgical in the 3rd quarter valued at approximately $525,000. Finally, Coldstream Capital Management Inc. grew its holdings in Intuitive Surgical by 26.2% during the 3rd quarter. Coldstream Capital Management Inc. now owns 11,561 shares of the medical equipment provider's stock valued at $5,773,000 after buying an additional 2,399 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.